These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22929911)

  • 1. Target practice: HDAC inhibitors for schizophrenia.
    Hyman SE
    Nat Neurosci; 2012 Sep; 15(9):1180-1. PubMed ID: 22929911
    [No Abstract]   [Full Text] [Related]  

  • 2. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.
    Kurita M; Holloway T; García-Bea A; Kozlenkov A; Friedman AK; Moreno JL; Heshmati M; Golden SA; Kennedy PJ; Takahashi N; Dietz DM; Mocci G; Gabilondo AM; Hanks J; Umali A; Callado LF; Gallitano AL; Neve RL; Shen L; Buxbaum JD; Han MH; Nestler EJ; Meana JJ; Russo SJ; González-Maeso J
    Nat Neurosci; 2012 Sep; 15(9):1245-54. PubMed ID: 22864611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptors as targets for novel antipsychotic treatments.
    Gray LJ; Hannan AJ; Zhang X
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1522-34. PubMed ID: 22283756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptors.
    Pilc A; Ossowska K
    Amino Acids; 2007 Feb; 32(2):165-7. PubMed ID: 17245617
    [No Abstract]   [Full Text] [Related]  

  • 5. HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.
    de la Fuente Revenga M; Ibi D; Saunders JM; Cuddy T; Ijaz MK; Toneatti R; Kurita M; Holloway T; Shen L; Seto J; Dozmorov MG; González-Maeso J
    Neuroscience; 2018 Sep; 388():102-117. PubMed ID: 30025863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glutamate receptors in antipsychotic drug action.
    Ossowska K; Pietraszek M; Wardas J; Nowak G; Zajaczkowski W; Wolfarth S; Pilc A
    Amino Acids; 2000; 19(1):87-94. PubMed ID: 11026477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group II metabotropic glutamate receptors and schizophrenia.
    Moreno JL; Sealfon SC; González-Maeso J
    Cell Mol Life Sci; 2009 Dec; 66(23):3777-85. PubMed ID: 19707855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor.
    Hiyoshi T; Marumo T; Hikichi H; Tomishima Y; Urabe H; Tamita T; Iida I; Yasuhara A; Karasawa J; Chaki S
    J Pharmacol Exp Ther; 2014 Dec; 351(3):642-53. PubMed ID: 25277141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
    Fell MJ; Svensson KA; Johnson BG; Schoepp DD
    J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeting metabotropic glutamate receptors to develop novel antipsychotics].
    Chaki S; Yoshida S; Okuyama S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Nov; 30(5-6):207-13. PubMed ID: 21226317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.
    Rodriguez AL; Grier MD; Jones CK; Herman EJ; Kane AS; Smith RL; Williams R; Zhou Y; Marlo JE; Days EL; Blatt TN; Jadhav S; Menon UN; Vinson PN; Rook JM; Stauffer SR; Niswender CM; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2010 Dec; 78(6):1105-23. PubMed ID: 20923853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment.
    Matosin N; Frank E; Deng C; Huang XF; Newell KA
    Schizophr Res; 2013 May; 146(1-3):170-6. PubMed ID: 23462049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia.
    Stansley BJ; Conn PJ
    Curr Opin Pharmacol; 2018 Feb; 38():31-36. PubMed ID: 29486374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia drug says goodbye to dopamine.
    Weinberger DR
    Nat Med; 2007 Sep; 13(9):1018-9. PubMed ID: 17828217
    [No Abstract]   [Full Text] [Related]  

  • 15. The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia.
    Maj C; Minelli A; Giacopuzzi E; Sacchetti E; Gennarelli M
    Curr Neuropharmacol; 2016; 14(5):540-50. PubMed ID: 27296644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
    Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neither typical nor atypical: LY404039 provides proof of concept that selective targeting of mGluR2/3 receptors is a valid mechanism for obtaining antipsychotic efficacy.
    Lebois EP
    Curr Top Med Chem; 2008; 8(16):1480-1. PubMed ID: 19006848
    [No Abstract]   [Full Text] [Related]  

  • 18. Biphasic Modulation of NMDA Receptor Function by Metabotropic Glutamate Receptors.
    O'Neill N; McLaughlin C; Komiyama N; Sylantyev S
    J Neurosci; 2018 Nov; 38(46):9840-9855. PubMed ID: 30282730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics.
    Walker AG; Conn PJ
    Curr Opin Pharmacol; 2015 Feb; 20():40-5. PubMed ID: 25462291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5).
    Stauffer SR
    ACS Chem Neurosci; 2011 Aug; 2(8):450-70. PubMed ID: 22860171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.